These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 3315932
1. Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial. Morgan MY, Hawley KE. Hepatology; 1987; 7(6):1278-84. PubMed ID: 3315932 [Abstract] [Full Text] [Related]
2. Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study. Morgan MY, Hawley KE, Stambuk D. J Hepatol; 1987 Apr; 4(2):236-44. PubMed ID: 3295020 [Abstract] [Full Text] [Related]
9. Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose. Lanthier PL, Morgan MY. Gut; 1985 Apr; 26(4):415-20. PubMed ID: 3979914 [Abstract] [Full Text] [Related]
10. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. Gluud LL, Vilstrup H, Morgan MY. Cochrane Database Syst Rev; 2016 Apr 18; 4():CD003044. PubMed ID: 27089005 [Abstract] [Full Text] [Related]
11. Lactitol or lactulose in the treatment of chronic hepatic encephalopathy: results of a meta-analysis. Blanc P, Daures JP, Rouillon JM, Peray P, Pierrugues R, Larrey D, Gremy F, Michel H. Hepatology; 1992 Feb 18; 15(2):222-8. PubMed ID: 1531204 [Abstract] [Full Text] [Related]
12. Treatment of porto-systemic encephalopathy with lactitol verus lactulose: a randomized controlled study. Pai CH, Huang YS, Jeng WC, Chan CY, Lee SD. Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jan 18; 55(1):31-6. PubMed ID: 7712392 [Abstract] [Full Text] [Related]
13. Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy. Patil DH, Westaby D, Mahida YR, Palmer KR, Rees R, Clark ML, Dawson AM, Silk DB. Gut; 1987 Mar 18; 28(3):255-9. PubMed ID: 3570029 [Abstract] [Full Text] [Related]
14. [A clinical comparative study of crystalline pure lactulose and powder pure lactitol in portasystemic encephalopathy of cirrhotic patients]. Grandi M, Sacchetti C, Pederzoli S, Celani MF. Minerva Gastroenterol Dietol; 1991 Mar 18; 37(4):225-30. PubMed ID: 1805974 [Abstract] [Full Text] [Related]
18. The effect of lactulose and lactitol administration on fecal fat excretion in patients with liver cirrhosis. Merli M, Caschera M, Piat C, Pinto G, Diofebi M, Riggio O. J Clin Gastroenterol; 1992 Sep 18; 15(2):125-7. PubMed ID: 1401823 [Abstract] [Full Text] [Related]
19. Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides. Morgan MY. Metab Brain Dis; 2016 Dec 18; 31(6):1361-1364. PubMed ID: 27638474 [Abstract] [Full Text] [Related]